Cited by 3Gastrointestinal motility and disordersGastrointestinal Bleeding Diagnosis and TreatmentGastroesophageal reflux and treatments

Clinical insights into diabetic gastroparesis: gastric scintigraphy-based diagnosis and treatment outcomes

Open access
Wifi, Mohamed-Naguib, El-Sherbiny, Mohamed, Mohamed, Rasha Sobh, Kandeel, Ahmed, Rizk, Sobhi Eid·2025·BMC Gastroenterology

Published version of a preprint

Abstract

Background: Long-standing diabetes mellitus (DM) can lead to macrovascular and microvascular complications, including autonomic neuropathy, which disrupts gut motility. Gastroparesis (GP) is defined as delayed gastric emptying of solids (with or without liquids) in the absence of any mechanical obstruction. The gold standard test for diagnosing gastroparesis is gastric scintigraphy (GS) using a solid meal. Gastroparesis poses diagnostic and therapeutic challenges, and can significantly impact patients with DM. The purpose of this study is to evaluate the prevalence of gastroparesis among symptomatic patients and assess treatment outcomes, with particular focus on identifying clinical predictors of delayed gastric emptying and factors associated with response to medical therapy in confirmed cases. Patients and methods: From June 2022 to June 2024, all patients visiting the diabetes clinic in Cairo University Hospital for any reason were screened for symptoms of gastroparesis using the gastroparesis cardinal symptom index (GCSI). Symptomatic patients underwent solid gastric scintigraphy. Those diagnosed with GP were treated for three months and refractory cases were offered G-POEM. Results: Thirty-two patients with moderate-to-severe symptoms of gastroparesis were the population of this study. Of these, 62.5% had delayed gastric emptying on solid gastric scintigraphy. A GCSI > 23 independently predicted delayed gastric emptying on solid gastric scintigraphy (OR 1.153, 95% CI (1.009–1.317), p = 0.036). 55% of GP patients achieved improvement in symptoms after three months of optimized medical therapy, and two out of four cases had sustained improvement for one year after G-POEM. The responders to medical treatment were significantly older, had lower GCSI and greater reduction in hemoglobin A1c (HbA1c) compared to those in the refractory group ( p = 0.046, 0.012, 0.012, respectively). Conclusion: This study highlighted the role of the GCSI in assessing and monitoring gastroparesis, particularly in resource-limited settings. Diabetic GP differs in clinical presentation and management from other types of GP. Optimizing glycemic control may contribute to symptoms improvement. Older age and lower symptoms burden at presentation may help identify patients more likely to benefit from medical therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12876-025-03977-x

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The integration of CGM with continuous subcutaneous insulin infusion (CSII) expands therapeutic possibilities, allowing for more precise and safer glycemic control, with possible improvements in HbA1c, gastrointestinal symptoms, tolerance to liquid meals and quality of life.

    “The integration of CGM with continuous subcutaneous insulin infusion (CSII) expands therapeutic possibilities, allowing for more precise and safer glycemic control, with possible improvements in HbA1c, gastrointestinal symptoms, tolerance to liquid meals and quality of life [135, 136, 147].”

    From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [147]

    Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wifi, M.-N., El-Sherbiny, M., Mohamed, R. S., Kandeel, A., & Rizk, S. E.
Affiliations
Cairo University (EG)
Corresponding author
Rizk, Sobhi Eid
Venue
BMC Gastroenterology
Published
2025-09-15
Volume
25
Issue
1
Pages
640-640
ISSN
1471-230X (ISSN-L)
OpenAlex
W4414179193
Cited by
3
References
35
Citations by year
2026: 3
FWCI
2.85
Type
journal article
Language
en
Open access
Locations
  • BMC Gastroenterology (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Cairo University
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
Keywords
diabetic gastroparesis, gastric emptying scintigraphy, delayed gastric emptying, Gastroparesis Cardinal Symptom Index, autonomic neuropathy, diabetes mellitus, gastric peroral endoscopic myotomy, medical therapy response, glycemic control, prevalence
MeSH terms
Adult, Aged, Female, Gastric Emptying, Humans, Male, Middle Aged, Radionuclide Imaging, Prevalence, Treatment Outcome, Gastroparesis, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review